Gastroenterology
Volume 138, Issue 5 , Pages 1697-1703.e2 , May 2010

Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

  • Sverre Söderlund

      Affiliations

    • Department of Medicine, Karolinska Institutet, Stockholm Söder Hospital, Stockholm, Sweden
    • Corresponding Author InformationReprint requests Address requests for reprints to: Sverre Söderlund, MD, Department of Medicine, Karolinska Institutet, Stockholm Söder Hospital, Stockholm, Sweden. fax: (46) 8-616-31-46
    • ,
  • Fredrik Granath

      Affiliations

    • Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    • Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    • ,
  • Olle Broström

      Affiliations

    • Department of Medicine, Karolinska Institutet, Stockholm Söder Hospital, Stockholm, Sweden
    • ,
  • Per Karlén

      Affiliations

    • Department of Medicine, Karolinska Institutet, Stockholm Söder Hospital, Stockholm, Sweden
    • ,
  • Robert Löfberg

      Affiliations

    • Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    • IBD Unit, Sophiahemmet, Stockholm, Sweden
    • ,
  • Anders Ekbom

      Affiliations

    • Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    • Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    • ,
  • Johan Askling

      Affiliations

    • Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
    • Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden

Received 21 August 2009 ,Accepted 2 February 2010.

References 

  1. Virchow R. Die krankhaften geschwulste. Berlin: August Hirschwald; 1863;
  2. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet. 2001;357:539–545
  3. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867
  4. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–459
  5. Levi F, La Vecchia C, Lucchini F, et al. Trends in cancer mortality sex ratios in Europe, 1950-1989. World Health Stat Q. 1992;45:117–164
  6. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121–124
  7. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science. 2007;317:124–127
  8. Soderlund S, Brandt L, Lapidus A, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009;136:1561–1567
  9. Swedish National Board of Health and Welfare (Socialstyrelsen). Statistical Databases - Cause of Death Statistics. http://www.socialstyrelsen.se/uppfoljning/statistik/statistikdatabasAccessed March 16, 2010
  10. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350–358
  11. Lapidus A, Bernell O, Hellers G, et al. Incidence of Crohn's disease in Stockholm County 1955–1989. Gut. 1997;41:480–486
  12. Lofberg R, Brostrom O, Karlen P, et al. Colonoscopic surveillance in long-standing total ulcerative colitis—a 15-year follow-up study. Gastroenterology. 1990;99:1021–1031
  13. Persson PG, Bernell O, Leijonmarck CE, et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 1996;110:1339–1345
  14. Nordenvall B, Brostrom O, Berglund M, et al. Incidence of ulcerative colitis in Stockholm County 1955–1979. Scand J Gastroenterol. 1985;20:783–790
  15. Winther KV, Jess T, Langholz E, et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004;2:1088–1095
  16. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854–862
  17. Persson PG, Karlen P, Bernell O, et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology. 1994;107:1675–1679
  18. Munkholm P, Langholz E, Davidsen M, et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology. 1993;105:1716–1723
  19. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357–359
  20. Karlen P, Lofberg R, Brostrom O, et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 1999;94:1047–1052
  21. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer (A population-based study). N Engl J Med. 1990;323:1228–1233
  22. Pinczowski D, Ekbom A, Baron J, et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994;107:117–120
  23. Moody GA, Jayanthi V, Probert CS, et al. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996;8:1179–1183
  24. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145–153
  25. Statistics Sweden. Statistics Sweden Web site http://www.scb.se/Accessed December 16, 2009
  26. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929–2933
  27. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535–1544
  28. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417–1426
  29. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med. 1999;106:574–582
  30. Jacobsen BK, Vollset SE, Kvale G. Do reproductive factors influence colorectal cancer survival?. J Clin Epidemiol. 1995;48:1119–1122
  31. Potter JD, Bostick RM, Grandits GA, et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev. 1996;5:779–784
  32. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350:991–1004
  33. Issa JP, Ottaviano YL, Celano P, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7:536–540
  34. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001;61:126–130
  35. Fujiwara I, Yashiro M, Kubo N, et al. Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway. Dis Colon Rectum. 2008;51:1387–1394
  36. Allison J, Herrinton LJ, Liu L, et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008;6:999–1003
  37. Wagtmans MJ, Verspaget HW, Lamers CB, et al. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol. 2001;96:1541–1546
  38. Cosnes J, Carbonnel F, Carrat F, et al. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut. 1999;45:218–222
  39. Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:1193–1196
  40. Jess T, Loftus EV, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130:1039–1046

 View this article's video abstract at www.gastrojournal.org.

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Swedish Medical Association, the Swedish Cancer Society.

PII: S0016-5085(10)00179-4

doi: 10.1053/j.gastro.2010.02.007

Gastroenterology
Volume 138, Issue 5 , Pages 1697-1703.e2 , May 2010

Article Tools

* Image Usage & Resolution